Quanterix Corp

NASDAQ:QTRX

4.81

+0.02 (+0.42%)

7:10:18 PM EDT: $4.70 -0.11 (-2.29%)

Market Cap (Intraday)	224.44M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$38.18 Million
Adjusted EPS	-$0.46

See more estimates

10-Day MA	$4.58
50-Day MA	$5.26
200-Day MA	$7.10

See more pivots

Quanterix Corp Stock, NASDAQ:QTRX

Building 1, 900 Middlesex Turnpike, Billerica, Massachusetts 01821

United States of America

Phone: +1.617.301.9400

Number of Employees:

http://www.quanterix.com

Description

Quanterix Corp. engages in the development of ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. Its products and services include Simoa Assay Kits, HD-X analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, 2470 Arrayer, Simoa Accelerator Laboratory, Uman NF-Light, and Homebrew -Custom Assay Development. The company was founded by Nicholas J. Naclerio and David R. Walt in April 2007 and is headquartered in Billerica, MA.